209 related articles for article (PubMed ID: 23242390)
1. Antipsychotic use by medicaid-insured youths: impact of eligibility and psychiatric diagnosis across a decade.
Zito JM; Burcu M; Ibe A; Safer DJ; Magder LS
Psychiatr Serv; 2013 Mar; 64(3):223-9. PubMed ID: 23242390
[TBL] [Abstract][Full Text] [Related]
2. Atypical antipsychotic use among Medicaid-insured children and adolescents: duration, safety, and monitoring implications.
Burcu M; Zito JM; Ibe A; Safer DJ
J Child Adolesc Psychopharmacol; 2014 Apr; 24(3):112-9. PubMed ID: 24690011
[TBL] [Abstract][Full Text] [Related]
3. Effect of Medicaid eligibility category on racial disparities in the use of psychotropic medications among youths.
Zito JM; Safer DJ; Zuckerman IH; Gardner JF; Soeken K
Psychiatr Serv; 2005 Feb; 56(2):157-63. PubMed ID: 15703342
[TBL] [Abstract][Full Text] [Related]
4. The Impact of a State Medicaid Peer-Review Authorization Program on Pediatric Use of Antipsychotic Medications.
Pennap D; Burcu M; Safer DJ; Zito JM
Psychiatr Serv; 2018 Mar; 69(3):293-299. PubMed ID: 29137557
[TBL] [Abstract][Full Text] [Related]
5. Second-generation antipsychotic use among stimulant-using children, by organization of medicaid mental health.
Saloner B; Matone M; Kreider AR; Budeir MS; Miller D; Huang YS; Raghavan R; French B; Rubin D
Psychiatr Serv; 2014 Dec; 65(12):1458-64. PubMed ID: 25179737
[TBL] [Abstract][Full Text] [Related]
6. Antipsychotic treatment among youth in foster care.
Dosreis S; Yoon Y; Rubin DM; Riddle MA; Noll E; Rothbard A
Pediatrics; 2011 Dec; 128(6):e1459-66. PubMed ID: 22106072
[TBL] [Abstract][Full Text] [Related]
7. Differences in Medicaid Antipsychotic Medication Measures Among Children with SSI, Foster Care, and Income-Based Aid.
Leckman-Westin E; Finnerty M; Scholle SH; Pritam R; Layman D; Kealey E; Byron S; Morden E; Bilder S; Neese-Todd S; Horwitz S; Hoagwood K; Crystal S
J Manag Care Spec Pharm; 2018 Mar; 24(3):238-246. PubMed ID: 29485947
[TBL] [Abstract][Full Text] [Related]
8. Anticonvulsant treatment for psychiatric and seizure indications among youths.
Zito JM; Safer DJ; Gardner JF; Soeken K; Ryu J
Psychiatr Serv; 2006 May; 57(5):681-5. PubMed ID: 16675763
[TBL] [Abstract][Full Text] [Related]
9. Trends in Antipsychotic Prescribing in Medicaid-Eligible Youth.
Edelsohn GA; Karpov I; Parthasarathy M; Hutchison SL; Castelnovo K; Ghuman J; Schuster JM
J Am Acad Child Adolesc Psychiatry; 2017 Jan; 56(1):59-66. PubMed ID: 27993230
[TBL] [Abstract][Full Text] [Related]
10. Multimodal treatment for ADHD among youths in three Medicaid subgroups: disabled, foster care, and low income.
dosReis S; Owens PL; Puccia KB; Leaf PJ
Psychiatr Serv; 2004 Sep; 55(9):1041-8. PubMed ID: 15345765
[TBL] [Abstract][Full Text] [Related]
11. Rapid Growth Of Antipsychotic Prescriptions For Children Who Are Publicly Insured Has Ceased, But Concerns Remain.
Crystal S; Mackie T; Fenton MC; Amin S; Neese-Todd S; Olfson M; Bilder S
Health Aff (Millwood); 2016 Jun; 35(6):974-82. PubMed ID: 27269012
[TBL] [Abstract][Full Text] [Related]
12. The relationship between mental health diagnosis and treatment with second-generation antipsychotics over time: a national study of U.S. Medicaid-enrolled children.
Matone M; Localio R; Huang YS; dosReis S; Feudtner C; Rubin D
Health Serv Res; 2012 Oct; 47(5):1836-60. PubMed ID: 22946905
[TBL] [Abstract][Full Text] [Related]
13. Concurrent mental health therapy among medicaid-enrolled youths starting antipsychotic medications.
Harris E; Sorbero M; Kogan JN; Schuster J; Stein BD
Psychiatr Serv; 2012 Apr; 63(4):351-6. PubMed ID: 22337007
[TBL] [Abstract][Full Text] [Related]
14. Second-Generation Antipsychotic Prescribing Patterns for Pediatric Patients Enrolled in West Virginia Medicaid.
Melvin KE; Hart JC; Sorvig RD
Psychiatr Serv; 2017 Oct; 68(10):1061-1067. PubMed ID: 28566023
[TBL] [Abstract][Full Text] [Related]
15. Comparative prevalence of psychotropic medications among youths enrolled in the SCHIP and privately insured youths.
Safer DJ; Zito JM; Gardner JF
Psychiatr Serv; 2004 Sep; 55(9):1049-51. PubMed ID: 15345766
[TBL] [Abstract][Full Text] [Related]
16. Changing trends in pediatric antipsychotic use in Florida's Medicaid program.
Constantine R; Tandon R
Psychiatr Serv; 2008 Oct; 59(10):1162-8. PubMed ID: 18832502
[TBL] [Abstract][Full Text] [Related]
17. Treatment of Young People With Antipsychotic Medications in the United States.
Olfson M; King M; Schoenbaum M
JAMA Psychiatry; 2015 Sep; 72(9):867-74. PubMed ID: 26132724
[TBL] [Abstract][Full Text] [Related]
18. The evolution of the State Children's Health Insurance Program (SCHIP) in New York: changing program features and enrollee characteristics.
Dick AW; Klein JD; Shone LP; Zwanziger J; Yu H; Szilagyi PG
Pediatrics; 2003 Dec; 112(6 Pt 2):e542. PubMed ID: 14654676
[TBL] [Abstract][Full Text] [Related]
19. Antipsychotic use at adult ambulatory care visits by patients with mental health disorders in the United States, 1996-2003: national estimates and associated factors.
Sankaranarayanan J; Puumala SE
Clin Ther; 2007 Apr; 29(4):723-41. PubMed ID: 17617297
[TBL] [Abstract][Full Text] [Related]
20. Multiple psychotropic medication use for youths: a two-state comparison.
dosReis S; Zito JM; Safer DJ; Gardner JF; Puccia KB; Owens PL
J Child Adolesc Psychopharmacol; 2005 Feb; 15(1):68-77. PubMed ID: 15741788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
